Recombinant Human CXCL2 protein (rFc Tag) (HPLC verified)
Species
Human
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg3423
Validation Data Gallery
Product Information
| Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
| Endotoxin | <0.1 EU/μg protein, LAL method |
| Activity |
Not tested |
| Expression | HEK293-derived Human CXCL2 protein Ala35-Asn107 (Accession# P19875) with a rabbit IgG Fc tag at the N-terminus. |
| GeneID | 2920 |
| Accession | P19875 |
| PredictedSize | 35.1 kDa |
| SDS-PAGE | 33-40 kDa, reducing (R) conditions |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Chemokine (C-X-C motif) ligand 2 (CXCL2) is a small cytokine belonging to the CXC chemokine family that is also called macrophage inflammatory protein 2-alpha (MIP2-alpha), Growth-regulated protein beta (Gro-beta) and Gro oncogene-2 (Gro-2). This chemokine is secreted by monocytes and macrophages and is chemotactic for polymorphonuclear leukocytes and hematopoietic stem cells. CXCL2 mobilizes cells by interacting with a cell surface chemokine receptor called CXCR2. During inflammation, the level of CXCL2 increases and is involved in the release of opioid peptides from leukocytes. Down-regulation of CXCL2 could reduce the recruitment of polymorphonuclear cells, which are key players in the clearance of L. monocytogenes during infection.
References:
1. Wolpe SD, et al. (1989). PNAS. 86(2):612-6. 2. Iida N, et al. (1990). Mol Cell Biol. 10(10):5596-9. 3. Pelus LM, et al. (2006). Exp Hematol. 34(8):1010-20. 4. Dagmar Hackel, et al (2010). NeuroImmune Biology. 9,237-250. 5. Febbraio MA. et al. (2005). Exerc Sport Sci Rev. 33:114-9. 6. L. Dortet, et al. (2019). Encyclopedia ofMicrobiology. 803-818.

